Evidence map›Paper›PMID 38610168›Full record

ArticleHealthcare (Basel, Switzerland)2024

Actuarial Analysis of Survival after Breast Cancer Diagnosis among Lithuanian Females.

Justina Levickytė, Aldona Skučaitė, Jonas Šiaulys, Rokas Puišys, Ieva Vincerževskienė

Abstract readCase Reports
In one paragraph

Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Justina LevickytėInstitute of Mathematics, Vilnius University, Naugarduko 24, LT-03225 Vilnius, Lithuania.
Aldona SkučaitėInstitute of Mathematics, Vilnius University, Naugarduko 24, LT-03225 Vilnius, Lithuania.
Jonas ŠiaulysInstitute of Mathematics, Vilnius University, Naugarduko 24, LT-03225 Vilnius, Lithuania.ORCID 0000-0002-8480-5644
Rokas PuišysInstitute of Mathematics, Vilnius University, Naugarduko 24, LT-03225 Vilnius, Lithuania.ORCID 0000-0003-3456-9054
Ieva VincerževskienėLaboratory of Clinical Oncology, National Cancer Institute, Santariškių 1, LT-08660 Vilnius, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most common cause of mortality due to cancer for women both in Lithuania and worldwide. The chances of survival after diagnosis differ significantly depending on the stage of disease at the time of diagnosis and other factors. One way to estimate survival is to construct a Kaplan-Meier estimate for each factor value separately. However, in cases when it is impossible to observe a large number of patients (for example, in the case of countries with lower numbers of inhabitants), dividing the data into subsets, say, by stage at diagnosis, may lead to results where some subsets contain too few data, thus causing the results of a Kaplan-Meier (or any other) method to become statistically incredible. The problem may become even more acute if researchers want to use more risk factors, such as stage at diagnosis, sex, place of living, treatment method, etc. Alternatively, Cox models can be used to analyse survival data with covariates, and they do not require the data to be divided into subsets according to chosen risks factors (hazards). We estimate the chances of survival for up to 5 years after a breast cancer diagnosis for Lithuanian females during the period of 1995-2016. Firstly, we construct Kaplan-Meier estimates for each stage separately; then, we apply a (stratified) Cox model using stage, circumstance of diagnosis, and year of diagnosis as (potential) hazards. Some directions of further research are provided in the last section of the paper.

Indexed as

breast cancercancer awareness campaigncentral death rateexposure to riskKaplan–Meier estimatestratified Cox modelsurvival analysis

Identifiers

PMID38610168
PMCPMC11012188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.